Study to Demonstrate the Safety and Effectiveness of | Clinical Research Studies Listing

Recruiting

18 years - 99 years

All

Phase 3

230 participants needed

1 Location

Brief description of study

This study aims to learn more about: if an experimental medication called benralizumab could be effective and safe in treating EG/EGE and also to better understand the studied disease and associated health problems.

Detailed description of study

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: Eosinophilic Gastritis, Gastroenteritis
Age: 18 years - 99 years
Gender: All

Diagnosed with Eosinophilic Gastritis and / or Gastroenteritis

Updated on 04 Aug 2024. Study ID: 849353

Find a site

Your Information has been sent successfully.

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.

Would you like to be notified about other trials? Sign up for Patient Notification Services.

Send a message

Enter your contact details to connect with study team

Primary Contact

First name*

Last name*

Email*

Phone number*

Preferred way of contact

Race

Ethnicity

Are you Healthy Volunteer

Are you comfortable with the informed consent process?

Yes

Other language

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).

Study to Demonstrate the Safety and Effectiveness of Benralizumab in Patients with Eosinophilic Gastritis and/or Gastroenteritis

Brief description of study

Detailed description of study

Eligibility of study

Find a site

Interested in the study